<div>A new study reports the development of nanoantibodies (nAbs) &ndash; also called or nanobodiesTM  or single-domain antibodies &ndash; that effectively bind the SARS-CoV-2 spike protein from the ancestral Wuhan variant as well as the recently detected UK and South African variants.</div>